| Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group 2000 · fibre group · Patients with a history of colorectal adenomas | 3.5 g | 3 years | 198 |
| [Plantago ovata (Laxomucil) after hemorrhoidectomy] 2004 · Plantago ovata group · Patients after open hemorrhoidectomy | 6.52 g | 20 days | 30 |
| Psyllium fiber vs. placebo in early treatment after STARR for obstructed defecation: a randomized double-blind clinical trial 2016 · active group · Patients after stapled transanal rectal resection (STARR) for obstructed defecation; age and sex not reported | 3.5 g | 26 weeks | 32 |
| Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU) 1999 · Plantago ovata seeds · Patients with ulcerative colitis in remission | 20 g | 1 year | 35 |
| Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU) 1999 · Plantago ovata seeds plus mesalamine · Patients with ulcerative colitis in remission | 20 g | 1 year | 30 |
| Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort-Results of an International Multicenter Randomized Controlled Trial 2023 · Psyllium · Adults aged 18–65 who were healthy controls or had functional constipation or constipation-predominant irritable bowel syndrome | 7.5 g | 4 weeks | 184 |
| Bulk agent Plantago ovata after Milligan-Morgan hemorrhoidectomy with Ligasure 2006 · first group · Patients undergoing open Milligan-Morgan hemorrhoidectomy with Ligasure; age and sex not specified | 6.52 g | 20 days | 49 |
| A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis 2009 · prebiotic group · Adults with ulcerative colitis | 8 g | 4 weeks | 31 |
| Usefulness of psyllium in rehabilitation of obstructed defecation 2011 · Group 2 · Women aged 46–71 with obstructed defecation | 7.2 g | — | 24 |
| A Randomized Pilot Study to Compare the Effectiveness of a Low FODMAP Diet vs Psyllium in Patients With Fecal Incontinence and Loose Stools 2022 · Psyllium · Adults aged 18 years and older with functional fecal incontinence and at least one weekly episode associated with loose stool | 6 g | 4 weeks | 22 |
| Psyllium supplementation in adolescents improves fat distribution & lipid profile: a randomized, participant-blinded, placebo-controlled, crossover trial 2012 · Psyllium (fibre) · Healthy adolescent males aged 15–16 years, recruited from lower socio-economic areas and selected as being at greater risk of metabolic syndrome; some were overweight or obese. | 6 g | 6 weeks | — |
| Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial 2017 · fiber · Children aged 7–18 years with irritable bowel syndrome | 6 g | 6 weeks | — |
| Satiety effects of psyllium in healthy volunteers 2016 · Study 1, 3.4 g psyllium · Healthy volunteers; age range and sex not reported | 6.8 g | 3 days | — |
| Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia 1998 · 3.4 g PSH/d group · Men and women with hypercholesterolemia and LDL-cholesterol concentrations between 3.36 and 5.68 mmol/L (130 and 220 mg/dL) | 3.4 g | 24 weeks | — |
| Cookies enriched with psyllium or oat bran lower plasma LDL cholesterol in normal and hypercholesterolemic men from Northern Mexico 1998 · Psyllium group · Sedentary men aged 20–45 years from Northern Mexico, normal or hypercholesterolemic | 1.3 g | 8 weeks | — |
| Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial 2009 · Psyllium · Adults aged 18-65 with irritable bowel syndrome | 10 g | 12 weeks | 85 |
| Dietary fiber supplementation for fecal incontinence: a randomized clinical trial 2014 · Psyllium group · Community-living adults aged 18 or older with fecal incontinence of loose or liquid feces | 14.6 g | 38 days | 54 |
| Symptoms associated with dietary fiber supplementation over time in individuals with fecal incontinence 2011 · psyllium group · Community-living adults aged 18 or older with fecal incontinence; predominantly middle-aged and female | 16.8 g | 52 days | 46 |
| Randomised clinical trial: mixed soluble/insoluble fibre vs. psyllium for chronic constipation 2016 · psyllium · Adults aged 18–75 with chronic constipation | 10 g | 4 weeks | 32 |
| The effect of 'Zesy002' kiwifruit (Actinidia chinensis var. chinensis) on gut health function: a randomised cross-over clinical trial 2019 · Metamucil · Women aged 21–65 with mild functional constipation or IBS with constipation | 14.5 g | 4 weeks | 32 |
| Effects of flax fiber on laxation and glycemic response in healthy volunteers 2005 · psyllium supplement (Study 1) · Healthy young adults; age range and sex not stated | 10.4 g | 2 weeks | 26 |
| Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation 2021 · psyllium · Adults with chronic constipation | 12 g | 4 weeks | 22 |
| Effect of four-day psyllium supplementation on bowel preparation for colonoscopy:A prospective double blind randomized trial [ISRCTN76623768] 2004 · Psyllium · Adults scheduled for elective colonoscopy for screening or symptom evaluation; predominantly male, non-constipated patients; age range not stated. | 20 g | 4 days | 20 |
| Agave tequilana Fructans Versus Psyllium plantago for Functional Constipation : Randomized Double-blind Clinical Trial 2024 · Group 4: PP 5 g+10 g MTDx · Adults with functional constipation; age and sex range not reported | 5 g | 8 weeks | 20 |
| Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia 1994 · Cholestyramine with psyllium hydrophilic mucilloid (PHM) · Adults with primary hypercholesterolemia and elevated LDL-C | 10.2 g | 6 weeks | 18 |
| The effect of a Plantago ovata seed containing preparation on appetite variables, nutrient and energy intake 1995 · Plantago ovata preparation · 17 female normal subjects classified as non-restrained eaters; age not reported | 40 g | 3 days | 17 |
| Starch-entrapped microsphere fibers improve bowel habit but do not exhibit prebiotic capacity in those with unsatisfactory bowel habits: a phase I, randomized, double-blind, controlled human trial 2017 · 12 g psyllium group · Adults aged 18–65, male and female, with self-described unsatisfactory bowel habits | 12 g | 12 weeks | 13 |
| Pharmacodynamics, Safety, and Tolerability of the NHE3 Inhibitor Tenapanor: Two Trials in Healthy Volunteers 2018 · 30 mg b.i.d. + psyllium · Healthy adult volunteers aged 19–65 years | 15 g | 7 days | 12 |
| Effects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipation 1995 · psyllium · Adults with idiopathic constipation | 10 g | 8 weeks | 11 |
| Mechanisms of constipation in older persons and effects of fiber compared with placebo 1995 · psyllium fiber · Older men and women with chronic constipation | 24 g | 30 days | 10 |
| Gastric cooling and menthol cause an increase in cardiac parasympathetic efferent activity in healthy adult human volunteers 2018 · 300 ml ispaghula husk solution at 6°C · Healthy adults; mean age 24.08 ± 9.36 years; sex not specified | 300 mL | 1 day | 9 |
| Moderation of lactulose-induced diarrhea by psyllium: effects on motility and fermentation 1998 · Lactulose with psyllium · Eight subjects; age, sex, and health condition not specified | 10.5 g | — | 8 |
| Digestibility and bulking effect of ispaghula husks in healthy humans 1994 · ispaghula · seven healthy volunteers | 18 g | 15 days | 7 |
| Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation 2011 · psyllium · Adults with chronic constipation; mean age 38 years; 3 male and 37 female | 22 g | 3 weeks | — |
| Satiety effects of psyllium in healthy volunteers 2016 · Study 1, 6.8 g psyllium · Healthy volunteers; age range and sex not reported | 13.6 g | 3 days | — |
| Satiety effects of psyllium in healthy volunteers 2016 · Study 1, 10.2 g psyllium · Healthy volunteers; age range and sex not reported | 20.4 g | 3 days | — |
| Effects of psyllium vs. placebo on constipation, weight, glycemia, and lipids: A randomized trial in patients with type 2 diabetes and chronic constipation 2018 · psyllium group · Patients with type 2 diabetes and chronic constipation; adults, sex not specified | 20 g | 12 weeks | — |
| Effect of flaxseed or psyllium vs. placebo on management of constipation, weight, glycemia, and lipids: A randomized trial in constipated patients with type 2 diabetes 2019 · psyllium group · Constipated patients with type 2 diabetes; age and sex not specified | 20 g | 12 weeks | — |
| Effects of psyllium on LDL-cholesterol concentrations in Brazilian children and adolescents: a randomised, placebo-controlled, parallel clinical trial 2015 · psyllium · Children and adolescents aged 6–19 years with mild-to-moderate hypercholesterolaemia | 7 g | 8 weeks | 26 |
| Ispaghula husk in the treatment of hypercholesterolaemia: a double-blind controlled study 1998 · 7.0 g/day ispaghula group · Adults aged 18–65 with mild-to-moderate primary hypercholesterolaemia | 7 g | 12 weeks | — |
| Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia 1998 · 6.8 g PSH/d group · Men and women with hypercholesterolemia and LDL-cholesterol concentrations between 3.36 and 5.68 mmol/L (130 and 220 mg/dL) | 6.8 g | 24 weeks | — |
| The Impact of Glucomannan, Inulin, and Psyllium Supplementation (Soloways(TM)) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial 2024 · glucomannan, inulin, and psyllium · Adults aged 40–60 with BMI of at least 25 and at least one minor allele in a specified FTO, LEP, LEPR, or MC4R polymorphism | 9 g | 180 days | 75 |
| Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial 2023 · Group B · Adults aged 18–70 with functional constipation | 5 g | 4 weeks | 50 |
| A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis 2009 · synbiotic group · Adults with ulcerative colitis | 8 g | 4 weeks | 32 |
| Sex and hormonal status influence plasma lipid responses to psyllium 2001 · psyllium supplement · 24 men, 23 premenopausal women, and 21 postmenopausal women; no diagnosed condition stated | 15 g | 30 days | 68 |
| Synergistic effects of psyllium in the dietary treatment of hypercholesterolemia 1990 · diet supplemented with psyllium · Adults with hypercholesterolemia and total serum cholesterol of 5.56–10.24 mmol/L (215–396 mg/dL); age and sex distribution not specified | 20.4 g | 90 days | 30 |
| Viscosity rather than quantity of dietary fibre predicts cholesterol-lowering effect in healthy individuals 2011 · medium-viscosity psyllium (PSY) · Apparently healthy adults aged 35 years on average, consuming a typical North American diet; 12 males and 11 females | 9 g | 3 weeks | 23 |
| Effects of psyllium hydrophilic mucilloid on LDL-cholesterol and bile acid synthesis in hypercholesterolemic men 1992 · psyllium (Ps) · Men aged 44 ± 4 years with moderate hypercholesterolemia | 15 g | 40 days | 20 |
| Ispaghula husk in the treatment of hypercholesterolaemia: a double-blind controlled study 1998 · 10.5 g/day ispaghula group · Adults aged 18–65 with mild-to-moderate primary hypercholesterolaemia | 10.5 g | 12 weeks | — |
| Long-term cholesterol-lowering effects of psyllium as an adjunct to diet therapy in the treatment of hypercholesterolemia 2000 · psyllium group · Men and women with primary hypercholesterolemia | 10.2 g | 26 weeks | — |
| Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives 2001 · psyllium · Treated hypertensive patients; age and sex not specified | 12 g | 8 weeks | — |
| Sex and hormonal status influence the effects of psyllium on lipoprotein remodeling and composition 2002 · psyllium (PSY) supplement · Men, premenopausal women, and postmenopausal women | 15 g | 30 days | — |
| Effect of combining psyllium fiber with simvastatin in lowering cholesterol 2005 · 10 mg simvastatin plus 15 g psyllium · Patients receiving simvastatin therapy | 15 g | 12 weeks | — |
| Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial 2007 · psyllium powder · hypertensive, overweight patients; age and sex not specified | 10.5 g | 26 weeks | — |
| Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia 2007 · isapgol plus atorvastatin group · Adults over 20 years of both sexes with hyperlipidaemia, LDL-C >130 mg/dl and total cholesterol >220 mg/dl | 11.2 g | 12 weeks | — |
| Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects 2007 · Psyllium · Adult male volunteers described as normal/healthy | 10 g | 4 weeks | — |
| Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects 2007 · Lovastatin plus psyllium · Adult male volunteers described as normal/healthy | 10 g | 4 weeks | — |
| Long-term effects of consuming foods containing psyllium seed husk on serum lipids in subjects with hypercholesterolemia 1998 · 10.2 g PSH/d group · Men and women with hypercholesterolemia and LDL-cholesterol concentrations between 3.36 and 5.68 mmol/L (130 and 220 mg/dL) | 10.2 g | 24 weeks | — |
| Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial 2023 · Group C · Adults aged 18–70 with functional constipation | 2 g | 4 weeks | 50 |
| Ultrahigh-viscosity hydroxypropylmethylcellulose blunts postprandial glucose after a breakfast meal in women 2012 · Psyllium fiber · Healthy adult women | 4 g | 1 day | 12 |
| A combination therapy including psyllium and plant sterols lowers LDL cholesterol by modifying lipoprotein metabolism in hypercholesterolemic individuals 2006 · treatment cookies (PSY+PS) · Healthy adults aged 35–65 years, male and female, with BMI 25–35 kg/m² and LDL cholesterol 2.6–4.1 mmol/L | 7.68 g | 4 weeks | 33 |
| A combination of psyllium and plant sterols alters lipoprotein metabolism in hypercholesterolemic subjects by modifying the intravascular processing of lipoproteins and increasing LDL uptake 2007 · PSY+PS test-cookie period · Hypercholesterolemic individuals; age and sex not stated | 7.28 g | 30 days | 33 |
| Dietary protein and soluble fiber reduce ambulatory blood pressure in treated hypertensives 2001 · soy protein and psyllium · Treated hypertensive patients; age and sex not specified | 12 g | 8 weeks | — |
| Psyllium reduces blood lipids in men and women with hyperlipidemia 1994 · Psyllium cereal (two test cereal types, results pooled) · Men and women with hyperlipidemia following a low-fat American Heart Association Step 2 diet | 6.7 g | 2 weeks | 42 |
| Method of administration influences the serum cholesterol-lowering effect of psyllium 1994 · psyllium-enriched cereal · modestly hypercholesterolemic subjects; age and sex not specified | 7.3 g | 2 weeks | 18 |
| Method of administration influences the serum cholesterol-lowering effect of psyllium 1994 · psyllium taken between meals · modestly hypercholesterolemic subjects; age and sex not specified | 7.6 g | 2 weeks | 18 |
| Chronic and postprandial responses of plasma insulin, glucose and lipids in volunteers given dietary fibre supplements 1995 · Psyllium · Healthy middle-aged men and women with above-normal fasting total cholesterol | 4.4 g | 1 day | 12 |
| Short-Term Supplementation of a Moderate Carbohydrate Diet with Psyllium Reduces Fasting Plasma Insulin and Tumor Necrosis Factor-α in Patients with Type 2 Diabetes Mellitus 2018 · MoCyllium group · Patients with type 2 diabetes, BMI 25–35 kg/m²; age and sex not specified | 7 g | 2 weeks | — |
| Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia 1995 · 2.5 g of colestipol plus 2.5 g of psyllium · Patients with moderate primary hypercholesterolemia after following a low-fat diet for 1 year | 7.5 g | 10 weeks | — |
| Soluble fiber enhances the hypocholesterolemic effect of the step I diet in childhood 1995 · Step I diet enriched with psyllium · Healthy children aged 2–11 years with two baseline LDL-C levels ≥110 mg/dL | 6.4 g | 12 weeks | — |
| Effect on Insulin, Glucose and Lipids in Overweight/Obese Australian Adults of 12 Months Consumption of Two Different Fibre Supplements in a Randomised Trial 2017 · psyllium supplement group (PSY) · Adults aged 19–68 years with overweight or obesity (BMI 25–47 kg/m²) | 15 g | 52 weeks | 53 |
| Reduction of small dense LDL and Il-6 after intervention with Plantago psyllium in adolescents with obesity: a parallel, double blind, randomized clinical trial 2021 · Plantago psyllium · Adolescents aged 15–19 years with obesity and BMI 29–34 | 10 g | 7 weeks | 50 |
| Lowering glycemic index of food by acarbose and Plantago psyllium mucilage 1998 · P. psyllium mucilage test · 12 patients with non-insulin-dependent diabetes mellitus and 10 healthy volunteers | 15 g | 1 day | 22 |
| Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging 2018 · Patients: psyllium 7 g t.d.s. · Adults with chronic constipation | 21 g | 6 days | 20 |
| Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies 2022 · Psyllium · Patients aged over 16 years with diarrhoea-predominant or constipation-predominant IBS | 20 g | 1 day | 19 |
| Soluble fibers from psyllium improve glycemic response and body weight among diabetes type 2 patients (randomized control trial) 2016 · intervention group · Men and women over 35 with newly identified type 2 diabetes, diagnosed within the previous year, taking anti-diabetes medication | 10.5 g | 8 weeks | 18 |
| The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls 2019 · Higher dose of psyllium (21 g/day) · Adults with chronic constipation meeting Rome III criteria for functional constipation or constipation-predominant irritable bowel syndrome | 21 g | 8 days | 16 |
| Long-term double-blind study on the influence of dietary fibres on faecal bile acid excretion in juvenile ulcerative colitis 1992 · ispaghula · 10 patients with juvenile ulcerative colitis in remission, orally treated with sulphasalazine; age and sex not reported | 16 g | 26 weeks | 10 |
| The acute effects of psyllium on postprandial lipaemia and thermogenesis in overweight and obese men 2008 · High-fibre meal (HFM) · Overweight and obese men | 15 g | 1 day | 10 |
| The Short-Term Effects and Tolerability of Low-Viscosity Soluble Fibre on Gastroparesis Patients: A Pilot Clinical Intervention Study 2021 · Psyllium husk (positive control) · Adult women with mild-to-moderate idiopathic or diabetic gastroparesis; ages 18 years or older | 10 g | 1 day | 10 |
| Psyllium husk fiber supplementation to the diets rich in soybean or coconut oil: hypocholesterolemic effect in healthy humans 1996 · Soybean oil plus psyllium fiber (SO + PF) · Healthy normolipidemic humans; age and sex not specified | 20 g | 7 days | 10 |
| Psyllium husk fiber supplementation to the diets rich in soybean or coconut oil: hypocholesterolemic effect in healthy humans 1996 · Coconut oil plus psyllium fiber (CO + PF) · Healthy normolipidemic humans; age and sex not specified | 20 g | 7 days | 10 |
| Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging 2018 · Controls: psyllium 7 g t.d.s. · Adults without constipation | 21 g | 6 days | 9 |
| Gastric cooling and menthol cause an increase in cardiac parasympathetic efferent activity in healthy adult human volunteers 2018 · 300 ml ispaghula husk solution at 37°C · Healthy adults; mean age 24.08 ± 9.36 years; sex not specified | 300 mL | 1 day | 9 |
| The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls 2019 · 14 g Metamucil (providing 7 g psyllium) · Healthy adults without digestive disorders | 21 g | 6 days | 9 |
| The Effect of Psyllium Husk on Intestinal Microbiota in Constipated Patients and Healthy Controls 2019 · 50:50 mixture of 7 g maltodextrin and 7 g Metamucil (providing 3.5 g psyllium) · Healthy adults without digestive disorders | 10.5 g | 6 days | 9 |
| Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhea induced by phenolphthalein 1993 · psyllium 9 g/day · Normal subjects with phenolphthalein-induced secretory diarrhea in a dose-response study | 9 g | — | 6 |
| Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhea induced by phenolphthalein 1993 · psyllium 18 g/day · Normal subjects with phenolphthalein-induced secretory diarrhea in a dose-response study | 18 g | — | 6 |
| Effect of psyllium, calcium polycarbophil, and wheat bran on secretory diarrhea induced by phenolphthalein 1993 · psyllium 30 g/day · Normal subjects with phenolphthalein-induced secretory diarrhea in a dose-response study | 30 g | — | 6 |
| Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia 1999 · psyllium group · Men with type 2 diabetes and mild-to-moderate hypercholesterolemia | 10.2 g | 8 weeks | — |
| Cholesterol-lowering effects of psyllium-enriched cereal as an adjunct to a prudent diet in the treatment of mild to moderate hypercholesterolemia 1992 · Psyllium-flake cereal group · Ambulatory individuals with mild to moderate hypercholesterolemia | 114 g | 6 weeks | — |
| Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients 2005 · Psyllium group · Adults with type II diabetes receiving antidiabetic drugs | 10.2 g | 8 weeks | — |
| Contrasting effects of viscous and particulate fibers on colonic fermentation in vitro and in vivo, and their impact on intestinal water studied by MRI in a randomized trial 2020 · Psyllium · Healthy volunteers; age and sex not reported | 15 g | 2 days | — |
| Combination therapy with colestipol and psyllium mucilloid in patients with hyperlipidemia 1995 · 5 g of psyllium · Patients with moderate primary hypercholesterolemia after following a low-fat diet for 1 year | 15 g | 10 weeks | — |
| Psyllium husk fibre supplementation to soybean and coconut oil diets of humans: effect on fat digestibility and faecal fatty acid excretion 1994 · SO+PF · Healthy humans | 20 g | 7 days | — |
| Psyllium husk fibre supplementation to soybean and coconut oil diets of humans: effect on fat digestibility and faecal fatty acid excretion 1994 · CO+PF · Healthy humans | 20 g | 7 days | — |
| Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat diets 1993 · Psyllium, high-fat diet group · Men and women aged 21 to 70 with primary hypercholesterolemia following a high-fat diet | 10.2 g | 8 weeks | — |
| Efficacy of psyllium in reducing serum cholesterol levels in hypercholesterolemic patients on high- or low-fat diets 1993 · Psyllium, low-fat diet group · Men and women aged 21 to 70 with primary hypercholesterolemia following a low-fat diet | 10.2 g | 8 weeks | — |
| Psyllium is superior to docusate sodium for treatment of chronic constipation 1998 · psyllium · People with chronic idiopathic constipation | 10.2 g | 2 weeks | — |
| Lipid- and glucose-lowering efficacy of Plantago Psyllium in type II diabetes 1998 · Plantago Psyllium · Patients with type II diabetes; age and sex not reported | 15 g | 6 weeks | — |
| A randomised, placebo-controlled trial in healthy humans of modified cellulose or psyllium evaluating the role of gelation in altering colonic gas production during inulin co-administration 2026 · psyllium husk (PSY) · Healthy adults; median age 27 years (IQR 24–32), 57% female | 15 g | 1 day | 30 |
| Psyllium reduces inulin-induced colonic gas production in IBS: MRI and in vitro fermentation studies 2022 · Inulin and psyllium · Patients aged over 16 years with diarrhoea-predominant or constipation-predominant IBS | 20 g | 1 day | 19 |
| Chronic and postprandial responses of plasma insulin, glucose and lipids in volunteers given dietary fibre supplements 1995 · Psyllium-citrus pectin mixture · Healthy middle-aged men and women with above-normal fasting total cholesterol | 4.4 g | 1 day | 12 |
| A Randomized Controlled Trial of a Herbal Compound for Improving Metabolic Parameters in Diabetic Patients with Uncontrolled Dyslipidemia 2019 · intervention group · Adults with type 2 diabetes and dyslipidemia despite statin therapy; age and sex not specified | 2 g | 12 weeks | 25 |
| Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging 2018 · Controls: psyllium 3.5 g t.d.s. · Adults without constipation | 10.5 g | 6 days | 9 |